Your browser doesn't support javascript.
Neutralization against XBB.1 and XBB.1.5 after omicron subvariants breakthrough infection or reinfection.
Chen, Jin-Jin; Li, Li-Bo; Peng, Hong-Hong; Tian, Shen; Ji, Bin; Shi, Chao; Qian, Cheng; Jiang, Wen-Guo; Liu, Mei-Chen; Li, Ting-Ting; Shen, Yuan; Fang, Li-Qun; Wang, Guo-Lin.
  • Chen JJ; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
  • Li LB; Department of Disease Control, Jining Center for Disease Control and Prevention, Jining, China.
  • Peng HH; Department of Disease Control, the Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University, Wuxi Center for Disease Control and Prevention, Wuxi, China.
  • Tian S; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
  • Ji B; Department of Disease Control, the Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University, Wuxi Center for Disease Control and Prevention, Wuxi, China.
  • Shi C; Department of Disease Control, the Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University, Wuxi Center for Disease Control and Prevention, Wuxi, China.
  • Qian C; Department of Disease Control, Jiangyin Center for Disease Control and Prevention, Jiangyin, Wuxi, China.
  • Jiang WG; Department of Disease Control, Jining Center for Disease Control and Prevention, Jining, China.
  • Liu MC; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
  • Li TT; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
  • Shen Y; Department of Disease Control, the Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University, Wuxi Center for Disease Control and Prevention, Wuxi, China.
  • Fang LQ; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
  • Wang GL; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Lancet Reg Health West Pac ; 33: 100759, 2023 Apr.
Article in English | MEDLINE | ID: covidwho-2289401
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines / Variants Language: English Journal: Lancet Reg Health West Pac Year: 2023 Document Type: Article Affiliation country: J.lanwpc.2023.100759

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines / Variants Language: English Journal: Lancet Reg Health West Pac Year: 2023 Document Type: Article Affiliation country: J.lanwpc.2023.100759